• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度非酒精性脂肪性肝病危险因素的评估:一项系统评价和荟萃分析。

Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis.

作者信息

Kannan Suthanthira, Nelliyanil Maria, Mendagudli Roopa, Rajeshwari Swetha, Kona Chandralekha, Kundapur Rashmi, Sathyanath Shreyaswi, Kulkarni Vaman, Aggarwal Sumit

机构信息

Department of Community Medicine, ESIC Medical College, Chennai, Tamil Nadu, India.

Department of Community Medicine, AJ Institute of Medical Sciences and Research Center, Mangalore, Karnataka, India.

出版信息

J Educ Health Promot. 2024 Jan 22;12:435. doi: 10.4103/jehp.jehp_208_23. eCollection 2023.

DOI:10.4103/jehp.jehp_208_23
PMID:38464628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10920698/
Abstract

INTRODUCTION

NAFLD is emerging as an important cause of liver disease in India. It is estimated that 16-32% of general population in India (nearly 120 million) has NAFLD.

OBJECTIVE

This study aimed to identify the risk factors of NAFLD and to identify the association of lifestyle (dietary and physical activity), genetic, and environmental factors with NAFLD in India.

MATERIALS AND METHODS

A systematic literature search was conducted using an international electronic database: PubMed (MEDLINE) and Google Scholar from the date of inception 31 March 2021 to 28 September 2021. We included studies examining patients with NAFLD: Adults above 18 years of age. Studies with or without a control population were both eligible. The studies with a diagnosis of NAFLD based solely on abnormal liver tests were excluded. We tried to get unpublished data but they were not of the quality of inclusion. Meta-analysis was performed using the software STATA 14.2 (StataCorp, College Station, TX, USA). For each of the studies, the standard error was calculated using the reported number of outcomes and the sample size. A forest plot was used to graphically represent the study-specific and pooled prevalence estimates for overall and subgroup analysis.

RESULTS

In a systematic review and meta-analysis of 8 studies including data from over 1800 individuals, we found that among components of lipid profile, LDL and HDL had a negative effects on NAFLD while triglycerides had a positive effect on NAFLD.

CONCLUSION

Type 2 Diabetes Mellitus, Hypertension, and Obesity were the potential risk factors for NAFLD but the evidence generated was only from single studies.

摘要

引言

非酒精性脂肪性肝病(NAFLD)正在成为印度肝脏疾病的一个重要病因。据估计,印度普通人群中有16%-32%(近1.2亿人)患有NAFLD。

目的

本研究旨在确定NAFLD的风险因素,并确定生活方式(饮食和体育活动)、遗传和环境因素与印度NAFLD之间的关联。

材料与方法

使用国际电子数据库进行系统的文献检索:从2021年3月31日开始至2021年9月28日的PubMed(MEDLINE)和谷歌学术。我们纳入了对NAFLD患者的研究:18岁以上的成年人。有或没有对照人群的研究均符合条件。仅基于肝脏检查异常诊断为NAFLD的研究被排除。我们试图获取未发表的数据,但它们不符合纳入标准。使用STATA 14.2软件(美国德克萨斯州大学站市的StataCorp公司)进行荟萃分析。对于每项研究,使用报告的结局数量和样本量计算标准误差。森林图用于以图形方式表示总体和亚组分析的研究特异性和合并患病率估计值。

结果

在一项对8项研究的系统评价和荟萃分析中,纳入了来自1800多名个体的数据,我们发现,在血脂谱成分中,低密度脂蛋白(LDL)和高密度脂蛋白(HDL)对NAFLD有负面影响,而甘油三酯对NAFLD有正面影响。

结论

2型糖尿病、高血压和肥胖是NAFLD的潜在风险因素,但所产生的证据仅来自单一研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/45d2e346aa7a/JEHP-12-435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/23f3ab3c5241/JEHP-12-435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/52765872f566/JEHP-12-435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/23e5cdc78d85/JEHP-12-435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/45d2e346aa7a/JEHP-12-435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/23f3ab3c5241/JEHP-12-435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/52765872f566/JEHP-12-435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/23e5cdc78d85/JEHP-12-435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e220/10920698/45d2e346aa7a/JEHP-12-435-g004.jpg

相似文献

1
Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis.印度非酒精性脂肪性肝病危险因素的评估:一项系统评价和荟萃分析。
J Educ Health Promot. 2024 Jan 22;12:435. doi: 10.4103/jehp.jehp_208_23. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.超重和肥胖人群中非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球患病率:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30. doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16.
4
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.代谢风险因素与非酒精性脂肪性肝病(NAFLD)患者发生进展性肝疾病的关系:基于人群的观察性研究的系统评价和荟萃分析。
PLoS Med. 2020 Apr 30;17(4):e1003100. doi: 10.1371/journal.pmed.1003100. eCollection 2020 Apr.
5
Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.印度非酒精性脂肪性肝病的患病率:一项系统评价与荟萃分析。
J Clin Exp Hepatol. 2022 May-Jun;12(3):818-829. doi: 10.1016/j.jceh.2021.11.010. Epub 2021 Nov 25.
6
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis.沙特阿拉伯非酒精性脂肪性肝病(NAFLD)的患病率:系统评价与荟萃分析
Cureus. 2023 Jun 12;15(6):e40308. doi: 10.7759/cureus.40308. eCollection 2023 Jun.
7
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
8
Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.肠道微生物治疗对非酒精性脂肪性肝病患者血脂谱的影响:伞式荟萃分析研究。
Syst Rev. 2023 Aug 21;12(1):144. doi: 10.1186/s13643-023-02299-x.
9
Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis.2型糖尿病与非酒精性脂肪性肝病:一项系统评价与荟萃分析
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S1-S7.
10

引用本文的文献

1
Incidence of Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) in the Female Population of North Karnataka: A Cross-Sectional Study.北卡纳塔克邦女性人群中非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)的发病率:一项横断面研究。
Cureus. 2024 Aug 6;16(8):e66257. doi: 10.7759/cureus.66257. eCollection 2024 Aug.

本文引用的文献

1
Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies.高血压与非酒精性脂肪性肝病之间的双向关联:观察性研究的系统评价与荟萃分析
Int J Endocrinol. 2022 Mar 24;2022:8463640. doi: 10.1155/2022/8463640. eCollection 2022.
2
Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis.瘦体重人群非酒精性脂肪性肝病的危险因素:一项系统评价和荟萃分析。
JGH Open. 2021 Oct 4;5(11):1236-1249. doi: 10.1002/jgh3.12658. eCollection 2021 Nov.
3
Variation in Lifestyle-Related Behavior Among Obese Indian Patients With Non-alcoholic Fatty Liver Disease.
肥胖的非酒精性脂肪性肝病印度患者生活方式相关行为的差异
Front Nutr. 2021 Apr 14;8:655032. doi: 10.3389/fnut.2021.655032. eCollection 2021.
4
The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women - A Cross-sectional Study from Southern India.病态肥胖女性非酒精性脂肪性肝病的患病率及预测因素——一项来自印度南部的横断面研究
Eur Endocrinol. 2020 Oct;16(2):152-155. doi: 10.17925/EE.2020.16.2.152. Epub 2020 Oct 6.
5
Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma.非酒精性脂肪性肝病相关肝细胞癌的新兴危险因素。
Hepatoma Res. 2020;6. doi: 10.20517/2394-5079.2020.16. Epub 2020 Jun 18.
6
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.代谢风险因素与非酒精性脂肪性肝病(NAFLD)患者发生进展性肝疾病的关系:基于人群的观察性研究的系统评价和荟萃分析。
PLoS Med. 2020 Apr 30;17(4):e1003100. doi: 10.1371/journal.pmed.1003100. eCollection 2020 Apr.
7
Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations.非酒精性脂肪性肝病:日益加重的负担、不良后果及关联
J Clin Transl Hepatol. 2020 Mar 28;8(1):76-86. doi: 10.14218/JCTH.2019.00051. Epub 2019 Dec 28.
8
From NASH to HCC: current concepts and future challenges.从 NASH 到 HCC:当前概念和未来挑战。
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428. doi: 10.1038/s41575-019-0145-7.
9
Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care.本地化肝病诊治(LOCATE)- 一项旨在初级保健中发现、评估和管理早期肝病的聚类随机可行性研究。
PLoS One. 2018 Dec 21;13(12):e0208798. doi: 10.1371/journal.pone.0208798. eCollection 2018.
10
Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh.孟加拉国非酒精性脂肪性肝病的患病率及危险因素
JGH Open. 2018 Mar 30;2(2):39-46. doi: 10.1002/jgh3.12044. eCollection 2018 Apr.